Chemed officer to sell 2,000 shares under Rule 144

Chemed Corporation (CHE) received a notice under Rule 144 that officer Kevin J. McNamara plans to sell 2,000 shares of common stock through Merrill Lynch on or about 08/21/2026.

Rhea-AI Filing Summary

Chemed Corporation (CHE) received a notice under Rule 144 that officer Kevin J. McNamara plans to sell 2,000 shares of common stock through Merrill Lynch on or about 08/21/2026. The shares relate to a stock award and stock exercise dated 02/14/2025. Chemed reports 13,069,961 shares outstanding, a baseline figure, not the amount being sold.

Key Figures

Shares to be sold: 2,000 shares Approximate date of sale: 08/21/2026 Shares outstanding: 13,069,961 shares +4 more

7 metrics

Shares to be sold 2,000 shares Planned sale of Chemed common stock under Rule 144

Approximate date of sale 08/21/2026 Planned Rule 144 sale date for 2,000 shares

Shares outstanding 13,069,961 shares Number of Chemed common shares outstanding reported in the notice

Aggregate market value (planned sale) 1,078,680 Aggregate market value column for the 2,000 shares to be sold

Prior 3-month sale shares 2,000 shares Shares sold by Kevin McNamara on 08/03/2026

Aggregate market value (prior sale) 1,079,024 Aggregate market value for the 2,000 shares sold on 08/03/2026

Stock award and exercise date 02/14/2025 Date of stock award and stock exercise related to the securities

Key Terms

Rule 144, Stock Award, Approximate Date of Sale

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Award financial

"Common | 02/14/2025 | Stock Award | Chemed Corporation"

Approximate Date of Sale financial

"08/21/2026 | NYSE 144: Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CHE disclose about upcoming share sales?

It discloses that officer Kevin J. McNamara intends to sell 2,000 shares of Chemed Corporation common stock under Rule 144 through Merrill Lynch, with an approximate sale date of 08/21/2026.

How many Chemed (CHE) shares are covered by this planned Rule 144 sale?

The notice covers a proposed sale of 2,000 shares of Chemed Corporation common stock. This is the number of shares indicated in the Rule 144 securities information section as “Number of Shares or Other Units To Be Sold.”

Who is selling Chemed (CHE) shares under this Form 144 and in what capacity?

The planned sale is for the account of Kevin J. McNamara, identified as an officer of Chemed Corporation. The filing provides his name in the “Name of Person for Whose Account the Securities are To Be Sold” field.

What is the approximate date of the planned Chemed (CHE) share sale?

The approximate date of sale disclosed is 08/21/2026. This date appears in the Rule 144 securities information section as the “Approximate Date of Sale” for the 2,000 shares of common stock.

How many Chemed (CHE) shares are reported as outstanding in this Form 144?

The filing reports 13,069,961 shares of Chemed Corporation common stock outstanding. This figure appears in the column for “Number of Shares or Other Units Outstanding” and serves as context, not as an offered amount.

Were any Chemed (CHE) shares sold by this person in the prior three months?

Yes. The Rule 144 notice lists a sale on 08/03/2026 of 2,000 shares of Chemed Corporation common stock, with an aggregate market value of 1,079,024 reported in the “Securities Sold During The Past 3 Months” section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/21/2026 - 03:56 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001207137
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chemed Corporation
SEC File Number	001-08351
Address of Issuer	2600 Chemed Center 255 E 5th St Cincinnati OHIO 45202
Phone	5137626690
Name of Person for Whose Account the Securities are To Be Sold	Kevin J McNamara
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 5905 E. Galbraith Rd Suite 7000 Cincinnati OH 45236	2000	1078680	13069961	08/21/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/14/2025	Stock Award	Chemed Corporation			2000	02/14/2025	Stock Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin McNamara 255 E. 5th St. Suite 2600 Cincinnati OH 45202	Chemed Corporation	08/03/2026	2000	1079024

144: Remarks and Signature

Remarks
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Marsha L. Conley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)